Pharma Aids Limited (DSE: PHARMAID)
Bangladesh
· Delayed Price · Currency is BDT 623.40
0.00 (0.00%)
At close: Oct 14, 2024
Pharma Aids Income Statement
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | Jun '19 Jun 30, 2019 | 2018 - 2014 |
| Revenue | 408.99 | 308.49 | 323.05 | 280.29 | 269.57 | 249.05 | Upgrade
|
| Revenue Growth (YoY) | 35.53% | -4.51% | 15.25% | 3.98% | 8.24% | 5.98% | Upgrade
|
| Cost of Revenue | 288.26 | 257.2 | 219.58 | 174.95 | 163.13 | 151.54 | Upgrade
|
| Gross Profit | 120.73 | 51.29 | 103.47 | 105.34 | 106.44 | 97.51 | Upgrade
|
| Selling, General & Admin | 43.34 | 37.32 | 45.63 | 38.17 | 33.55 | 29.89 | Upgrade
|
| Other Operating Expenses | 0.1 | 2.21 | 1.94 | 0.07 | 0.12 | 0.68 | Upgrade
|
| Operating Expenses | 44.54 | 40.63 | 49.45 | 39.02 | 34.61 | 31.67 | Upgrade
|
| Operating Income | 76.18 | 10.66 | 54.02 | 66.33 | 71.84 | 65.84 | Upgrade
|
| Interest Expense | -0.27 | -0.24 | -0.38 | -0.9 | -0.89 | -1.28 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.12 | -0.13 | -0.09 | -0.07 | -0.14 | -0.14 | Upgrade
|
| EBT Excluding Unusual Items | 75.82 | 10.3 | 53.54 | 65.35 | 70.81 | 64.41 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | - | -0.84 | - | Upgrade
|
| Pretax Income | 75.82 | 10.3 | 53.54 | 65.35 | 69.97 | 64.41 | Upgrade
|
| Income Tax Expense | 25.07 | 16.68 | 18.78 | 15.1 | 17.49 | 16.1 | Upgrade
|
| Net Income | 50.75 | -6.38 | 34.76 | 50.26 | 52.47 | 48.31 | Upgrade
|
| Net Income to Common | 50.75 | -6.38 | 34.76 | 50.26 | 52.47 | 48.31 | Upgrade
|
| Net Income Growth | - | - | -30.83% | -4.22% | 8.62% | 2.77% | Upgrade
|
| Shares Outstanding (Basic) | 3 | 3 | 3 | 3 | 3 | 3 | Upgrade
|
| Shares Outstanding (Diluted) | 3 | 3 | 3 | 3 | 3 | 3 | Upgrade
|
| EPS (Basic) | 16.27 | -2.05 | 11.14 | 16.11 | 16.82 | 15.48 | Upgrade
|
| EPS (Diluted) | 16.27 | -2.05 | 11.14 | 16.11 | 16.82 | 15.48 | Upgrade
|
| EPS Growth | - | - | -30.83% | -4.22% | 8.62% | 2.77% | Upgrade
|
| Free Cash Flow | 27.91 | 5.06 | 29.15 | 21.12 | 35.69 | 23.3 | Upgrade
|
| Free Cash Flow Per Share | 8.95 | 1.62 | 9.34 | 6.77 | 11.44 | 7.47 | Upgrade
|
| Dividend Per Share | 1.000 | 1.000 | 5.000 | 5.000 | 5.000 | 5.000 | Upgrade
|
| Dividend Growth | -80.00% | -80.00% | 0% | 0% | 0% | 0% | Upgrade
|
| Gross Margin | 29.52% | 16.63% | 32.03% | 37.58% | 39.49% | 39.15% | Upgrade
|
| Operating Margin | 18.63% | 3.46% | 16.72% | 23.66% | 26.65% | 26.44% | Upgrade
|
| Profit Margin | 12.41% | -2.07% | 10.76% | 17.93% | 19.47% | 19.40% | Upgrade
|
| Free Cash Flow Margin | 6.82% | 1.64% | 9.02% | 7.54% | 13.24% | 9.36% | Upgrade
|
| EBITDA | 83.3 | 18.29 | 61.84 | 74.58 | 80.41 | 75.09 | Upgrade
|
| EBITDA Margin | 20.37% | 5.93% | 19.14% | 26.61% | 29.83% | 30.15% | Upgrade
|
| D&A For EBITDA | 7.12 | 7.62 | 7.82 | 8.25 | 8.57 | 9.25 | Upgrade
|
| EBIT | 76.18 | 10.66 | 54.02 | 66.33 | 71.84 | 65.84 | Upgrade
|
| EBIT Margin | 18.63% | 3.46% | 16.72% | 23.66% | 26.65% | 26.44% | Upgrade
|
| Effective Tax Rate | 33.06% | 161.99% | 35.07% | 23.10% | 25.00% | 25.00% | Upgrade
|
| Advertising Expenses | - | 0.89 | 0.97 | 0.96 | 0.8 | 0.92 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.